InsiderSignalSign in
← Insider buys

Michael P Dube has sold NTLA and made no open-market buys since Oct 2024

VP and Chief Accounting Officer at Intellia Therapeutics, Inc.

SEC CIK 0002019493 · Filings on SEC.gov ↗

$0Bought
$110KSold
NoneLast buy

Every filing

3 filings since Oct 2024, newest first

NTLASell

Intellia Therapeutics, Inc.

VP and Chief Accounting Officer

$44K−3.8%Jul 6
NTLASell

Intellia Therapeutics, Inc.

VP and Chief Accounting Officer

$28K−5.0%Jan 7
NTLASell

Intellia Therapeutics, Inc.

VP and Chief Accounting Officer

$38K−4.0%Oct 4
About Michael P Dube

Michael P. Dube is Vice President and Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA), where he has recently engaged in insider trading activities as a corporate insider. His current role involves overseeing the company's accounting operations and financial reporting.

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.